Drugs / JR-131
last change Mar 2018 re-read 2 minutes ago

JR-131

Developed for
anemia
Investigated by
JCR Pharmaceuticals Co., Ltd. · Kissei Pharmaceutical Co., Ltd.

Trials 2 · a red edge is where a trial was stopped

2017201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT02912533 Sep 2016 → Mar 2018 anemia Kissei Pharmaceutical Co., Ltd. Completed No outcome recorded
Phase 3 NCT02912494 Sep 2016 → Sep 2017 anemia Kissei Pharmaceutical Co., Ltd. Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as JR-131 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02912533
1

NCT02912494